| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 175 | 195 | 445 | 510 |
| Short-term investments | NaN | 0 | 0 | 0 |
| Accounts receivable, net of allowances of 3 (2026) and 4 (2025) | 273 | 253 | 259 | 240 |
| Inventories | 152 | 153 | 155 | 149 |
| Prepaid expenses | 15 | 34 | 30 | 28 |
| Current tax receivable | 12 | 2 | 13 | 3 |
| Other current assets | 40 | 16 | 19 | 20 |
| Total current assets | 667 | 652 | 922 | 951 |
| Long-term investments | 27 | 28 | 28 | 27 |
| Property, plant and equipment, net | 157 | 144 | 124 | 117 |
| Operating lease right of use assets, net | 22 | 26 | 30 | 35 |
| Goodwill and other intangible assets, net | 2 | 2 | NaN | 7 |
| Deferred tax assets | 296 | 323 | 285 | 270 |
| Other noncurrent assets | 26 | 27 | 27 | 44 |
| Total assets | 1,197 | 1,201 | 1,416 | 1,452 |
| Accrued rebates and product returns | 551 | 582 | 613 | 709 |
| Accounts payable and accrued expenses | 178 | 250 | 215 | 196 |
| Accrued litigation settlement expenses, current | 14 | 42 | 106 | 105 |
| Current portion of long-term debt | 0 | 29 | 18 | 18 |
| Operating lease liabilities, current | 9 | 10 | 10 | 11 |
| Income taxes payable | 26 | 2 | 4 | 17 |
| Other current liabilities | NaN | 0 | 0 | 0 |
| Total current liabilities | 779 | 914 | 965 | 1,056 |
| Long-term debt, less current portion | 486 | 290 | 304 | 308 |
| Accrued litigation settlement expenses, noncurrent | 41 | 52 | 300 | 299 |
| Operating lease liabilities, noncurrent | 14 | 22 | 24 | 29 |
| Other noncurrent liabilities | 21 | 21 | 30 | 18 |
| Total liabilities | 1,341 | 1,300 | 1,623 | 1,709 |
| Common stock, par value 0.50 per share issued shares 125 (2025) and 125 (2024) | NaN | 62 | 62 | 62 |
| Additional paid-in capital | 165 | 112 | 109 | 101 |
| Share repurchase commitment | NaN | 0 | 0 | 0 |
| Accumulated other comprehensive loss | -29 | -30 | -32 | -33 |
| Accumulated deficit | -280 | -243 | -346 | -388 |
| Total stockholders' deficit | -144 | -98 | -207 | -257 |
| Total liabilities and stockholders' deficit | 1,197 | 1,201 | 1,416 | 1,452 |
Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals, Inc. (INDV)